Optimizing the role of FDG PET–CT for potentially operable metastatic colorectal cancer

被引：0
|
作者：
A. D. Culverwell
F. U. Chowdhury
A. F. Scarsbrook
机构：
[1] Leeds Teaching Hospitals NHS Trust,Departments of Clinical Radiology and Nuclear Medicine
[2] St James’s University Hospital,Department of Nuclear Medicine
来源：
Abdominal Imaging | 2012年 / 37卷
关键词：
Colonic carcinoma; Rectal carcinoma; Fluorine fluorodeoxyglucose; Positron emission tomography–computed tomography; Metastatic disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Recent treatment advances now allow a realistic chance of cure in selected patients with metastatic colorectal carcinoma (CRC). Accurate pre-treatment staging is crucial to ensure appropriate management by identification of patients with more advanced disease who will not benefit from surgery. 18Fluorine 2-fluoro-2-deoxy-d-glucose positron emission tomography–computed tomography (PET–CT) has a firmly established role in staging, restaging, and recurrence detection of a range of tumors. This article will review the role of PET–CT in patients with CRC with a particular emphasis on optimizing the technique in patients with potentially operable metastatic disease.
引用
收藏
页码：1021 / 1031
页数：10
相关论文
共 50 条
  • [1] Optimizing the role of FDG PET-CT for potentially operable metastatic colorectal cancer
    Culverwell, A. D.
    Chowdhury, F. U.
    Scarsbrook, A. F.
    ABDOMINAL IMAGING, 2012, 37 (06): : 1021 - 1031
  • [2] Clinical impact of FDG PET-CT in patients with potentially operable metastatic colorectal cancer
    Briggs, R. H.
    Chowdhury, F. U.
    Lodge, J. P. A.
    Scarsbrook, A. F.
    CLINICAL RADIOLOGY, 2011, 66 (12) : 1167 - 1174
  • [3] Implication of FDG-PET/CT in patients with potentially operable colorectal lung metastases
    Uporov, Anton
    Taber, Samantha
    Schwarz, Lope Estevez
    Groene, Joern
    Pilz, Lothar R.
    Foerster, Gregor
    Bittner, Roland
    Pfannschmidt, Joachim
    INNOVATIVE SURGICAL SCIENCES, 2022, 6 (03): : 89 - 95
  • [4] The role of FDG-PET CT in colorectal cancer
    Jafferbhoy, S.
    Chambers, A.
    Mander, J.
    Paterson, H.
    BRITISH JOURNAL OF SURGERY, 2012, 99 : 88 - 88
  • [5] Role of FDG-PET/CT in the staging of colorectal cancer
    Storto, G.
    Mainenti, P.
    Varrone, A.
    Mainolfi, C.
    Salvatore, B.
    Caprio, M.
    Cella, L.
    Soricelli, A.
    Pace, L.
    Salvatore, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2006, 33 : S261 - S261
  • [6] The role of FDG PET/CT in patients with colorectal cancer metastases
    Kochhar, Rohit
    Liong, Sue
    Manoharan, Prakash
    CANCER BIOMARKERS, 2010, 7 (4-5) : 235 - 248
  • [7] FDG PET/CT in colorectal cancer
    Rodriguez-Fraile, M.
    Cozar-Santiago, M. P.
    Sabate-Llobera, A.
    Caresia-Aroztegui, A. P.
    Delgado Boltone, R. C.
    Orcajo-Rincon, J.
    De Arcocha-Torres, M.
    Garcia-Velloso, M. J.
    Garcia-Talavera, P.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, 2020, 39 (01): : 57 - 66
  • [8] Chemotherapy Response Evaluation in Metastatic Colorectal Cancer with FDG PET/CT and CT Scans
    Monteil, J.
    Mahmoudi, N.
    Leobon, S.
    Roudaut, P. Y.
    El Badaoui, A.
    Verbeke, S.
    Venat-Bouvet, L.
    Martin, J.
    Le Brun-Ly, V.
    Lavau-Denes, S.
    Maubon, A.
    Bouillet, P.
    Pouquet, M.
    Vandroux, J. C.
    Tubiana-Mathieu, N.
    ANTICANCER RESEARCH, 2009, 29 (07) : 2563 - 2568
  • [9] Prognostic value of staging FDG PET/CT in patients with metastatic colorectal cancer
    Choi, E. K.
    Oh, J. K.
    Chung, Y-A.
    ANNALS OF ONCOLOGY, 2018, 29
  • [10] FDG-PET and PET/CT in Colorectal Cancer
    Lonneux, Max
    PET CLINICS, 2008, 3 (02) : 147 - +
12345